Comments commented [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2010-02-11 09:19 (5561 d 00:59 ago) – Posting: # 4749
Views: 23,582

Dear Helmut,

❝ A comment on replicate designs (page 185) As there is still some controversy ...

❝ ... What statistical analyses to be used? How to evaluate a replicate design in an average BE approach?


❝ Was answered by: It is out of the scope of the guideline to give details on how to analyse the data of a replicate design, since it is standard statistical analysis.

(emphases by me)

How wonderful! Congratulation! :clap:
In German: Da bleibt einem ja die Spucke weg.
(no translation of this idiom. roughly: leaves one speechless)


Edit: See the follow-up thread. [Helmut]

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
73 visitors (0 registered, 73 guests [including 8 identified bots]).
Forum time: 11:19 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5